Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Novartis raises long-term sales targets, boosts outlook for key medicines and outlines a pipeline strategy driving growth throu...
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 203...
https://www.canada.ca/en/competition-bureau/news/2025/11/competition-bureau-expands-its-investigation-into-bwx-technologies-acq...
AI breakthroughs in pharma are pushing Eli Lilly and healthcare stocks higher—and may soon reshape how we fight cancer.
President Donald Trump announced a framework for a trade deal with Switzerland and Liechtenstein on Friday.
Novartis' GanLum met key Phase 3 goals, showing strong efficacy and safety in malaria patients, including against resistant...
Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand th...
Terns Pharmaceuticals shares rise after TERN-701 shows a 75% response rate in the CML trial, and William Blair upgrades the sto...
